Physician

Peter M Rao, MD

According to 2025 Medicare claims, Peter Rao, MD (NPI: 1932250339) practices interventional cardiology in the Dothan, AL market, with the plurality of this provider's patient population coming from Houston, AL. This provider's primary affiliated billing organization is RAO HEART & VASCULAR LLC (NPI: 1831864891; TIN: 871712276) and primary practice location at 36303-7013. Rao is affiliated with the CHSPSC ACO 12, LLC (ACO ID: A3722) and Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,420 traditional Medicare patients, billed 4,565 HCPCS/CPT codes, and received $264,732 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 4,862 prescription claims across 710 beneficiaries totaling $1,194,378 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 12 claims. Open Payments data shows 60 records totaling $1,764. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $327,356 and ending at $264,732. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $296,969 to $1,194,378. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $61,581 and ending at $29,447.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,645	4,873	$327,356
2016	1,630	5,508	$356,785
2017	1,558	6,117	$386,861
2018	1,517	6,196	$392,085
2019	1,593	6,590	$436,018
2020	1,319	4,867	$317,648
2021	1,169	4,290	$300,677
2022	1,297	8,084	$553,685
2023	1,265	5,482	$318,447
2024	1,420	4,565	$264,732

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	440	5,161	$296,969
2016	470	5,723	$386,207
2017	479	5,981	$500,288
2018	530	5,827	$567,416
2019	534	5,451	$590,291
2020	596	5,450	$722,451
2021	638	5,290	$824,329
2022	734	5,170	$1,010,060
2023	789	5,614	$1,202,562
2024	710	4,862	$1,194,378

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	62	$60,851
2016	N/R	45	$40,352
2017	N/R	72	$57,907
2018	N/R	43	$27,629
2019	N/R	32	$64,826
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	15	$33,964
2023	N/R	12	$28,882
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	188	188	$174
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	474	486	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	215	229	$93
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	415	429	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	330	776	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	511	22,742	$435,293
Camzyos	Mavacamten	30	900	$255,454
Entresto	Sacubitril/Valsartan	117	6,255	$124,668
Farxiga	Dapagliflozin Propanediol	120	5,519	$100,797
Xarelto	Rivaroxaban	94	5,130	$92,761

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	60	$1,764	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter M. Rao, MD?

Tedicare shows public-source Medicare data for Peter M. Rao, MD (NPI 1932250339), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter M. Rao, MD have ACO affiliation data?

Peter M. Rao, MD is shown with ACO affiliation data for CHSPSC ACO 12, LLC (MSSP, ACO ID A3722) and Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Peter M. Rao, MD?

Peter M. Rao, MD is linked to RAO HEART & VASCULAR LLC (billing NPI 1831864891) in the available physician profile data.

Does Peter M. Rao, MD have Open Payments data?

Peter M. Rao, MD has 60 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.